genglob magazine

Stanford University researchers used nanotechnology and magnetics to create a biosensor that they said should be able to detect cancer in its early stages, making a cure more likely. The sensor, which sits on a microchip, is 1,000 times more sensitive than cancer detectors used clinically today, according to scientists at Stanford, in Palo Alto, Calif. The researchers announced this week that the sensors have been effective in finding early-stage tumors in mice, giving them hope that it can be equally successful in detecting elusive cancers in humans. Read the rest of this entry »

Biocon Limited, in alliance with the US-based Abraxis Bio Science, today announced the launch of Abraxane, an oncotheraputic drug for treatment of breast cancer, in India. The drug could be administered if combination therapy for metastatic disease failed or there was relapse within six months of adjuvant chemotherapy. The drug has been approved by the Drug Controller General of India in October 2007. Read the rest of this entry »